Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹185 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹263 Cr
Mar2023₹224 Cr
Mar2022₹220 Cr
Mar2017₹185 Cr
Mar2016₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2024 ₹263 Cr
17.45
Mar2023 ₹224 Cr
2.09
Mar2022 ₹220 Cr
18.85
Mar2017 ₹185 Cr
0.50
Mar2016 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,766.3 Cr 9.3% -10.8% 14.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,557.0 Cr 2.3% -0.8% 32.7% Stock Analytics
DIVIS LABORATORIES ₹156,994.0 Cr 3.2% 1.1% 51.5% Stock Analytics
CIPLA ₹116,494.0 Cr 0.3% -2% 10% Stock Analytics
DR REDDYS LABORATORIES ₹109,297.0 Cr -1.8% 2.7% 12.7% Stock Analytics
ZYDUS LIFESCIENCES ₹100,035.0 Cr 2% 1.5% 38% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

9.3%

-10.8%

14.8%

SENSEX

-1%

-5%

5.6%


You may also like the below Video Courses